Patients receiving intensive chemotherapy of their NBT showed significantly reduced tumor tissue expression of USP24, USP34, MINDY2, USP8, JOSD1, USP52, and USP12 when compared to the observation group. This evidence concerns the gene USP12 and neoplasm.